| Phase 2 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 2 | ||||
| NCT05460000 | A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3… | Ovarian Cancer | Recruiting | 2026-07-27 |
| NCT04575961 | Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent… | Ovarian Cancer | Active, Not Recruiting | 2026-10-02 |
| NCT02203760 | Pazopanib Vs. Pazopanib Plus Gemcitabine | Leiomyosarcoma or Carcinosarcoma | Active, Not Recruiting | 2024-11-15 |
| Not specified | ||||
| NCT03503799 | Reaching for Evidence-baSed Chemotherapy Use in Endocrine Sensitive Breast Cancer | Primary Invasive Breast Cancer | Active, Not Recruiting | 2026-04-13 |
Ovarian Cancer (2) · Breast Cancer (1) · Sarcoma (1)